Competitive Grants Program
Pfizer supports the global healthcare community’s independent initiatives (e.g., research, quality improvement or education) to improve patient outcomes in areas of unmet medical need that are aligned with Pfizer’s medical and/or scientific strategies.
Pfizer’s competitive grant program involves a publicly posted Request for Proposal (RFP) that provides detail regarding a specific area of interest and sets timelines for review and approval. Organizations are invited to submit an application addressing the specific gaps in research, practice or care as outlined in the specific RFP. The grant requester (and ultimately the grantee) is responsible for the design, implementation, sponsorship, and conduct of the independent initiative supported by the grant, including compliance with any regulatory requirements.
Sign up to receive all grant announcements, including Request for Proposal (RFP) postings.
Sign Up for Alerts DetailsTitle Grant Type Focus Area Country Application Due Date Efforts to Improve Quality of Migraine CareRelease Date:Partner: The Japanese Headache SocietyQuality Improvement Internal Medicine Japan Improving Health Outcomes in Patients with ATTR-CM Through the Development of a Shared Decision-Making Tool (Decision Aid)Release Date:Research Rare Disease USA 2026 Hemophilia Fellowship – United StatesRelease Date:Fellowship Rare Disease All Improving Precision Oncology Care Through Molecular Diagnostic Integration and Data Quality ImprovementRelease Date:Quality Improvement Oncology Kazakhstan Implementing Germline and Somatic Testing for Precision Medicine in Community-Based Prostate Cancer CareEducation Oncology USA Improving Shared Decision Making in Hemophilia: Visiting Professorship ProgramRelease Date:Partner: Hemostasis & Thrombosis Research Society (HTRS)Education Rare Disease USA Improving Metastatic Prostate Cancer (mPCa) Care Through Innovative StrategiesRelease Date:Quality Improvement Oncology All Novel Therapies for Relapsed/Refractory Large B-Cell Lymphoma in Community Oncology PracticeRelease Date:Education Oncology USA Real-World Data Generation with Elranatamab in Relapsed/Refractory Multiple MyelomaRelease Date:Research Oncology China, France, Germany, Italy, Japan, Spain, Turkey, United Kingdom Pre-clinical Investigation of anti-TFPI-mediated Rebalancing Mechanisms in Non-Hemophilic Bleeding DisordersRelease Date:Research Rare Disease All Title Grant Type Focus Area Country Application Due Date Updates in RSV Prevention for Prenatal Care Workers Serving Marginalized CommunitiesRelease Date:Education Vaccines USA Acquired Aplastic Anemia: Educational programs to upskill hematologists & primary care physicians with current best practicesRelease Date:Education Hospital All Bridging the Inflammatory Dermatosis Care Divide with TeledermatologyRelease Date:Partner: The George Washington UniversityQuality Improvement Inflammation & Immunology USA Knowledge Gaps in Drug-Drug Interactions in COVID-19 Outpatient TreatmentRelease Date:Education Vaccines USA Optimizing COVID-19 Treatment Strategies in Elderly Vulnerable Populations in CanadaRelease Date:Quality Improvement Vaccines Canada Transthyretin Amyloid Cardiomyopathy (ATTR-CM) Research in CanadaRelease Date:Research Rare Disease Canada Improving access to and the quality of clinical diagnostic solutions (Africa Geographic Scope)Release Date:Quality Improvement Support for the Professions All Patient Education and Support for the Management of MigraineRelease Date:Education Internal Medicine All Advancing Management and Care in Atrial Fibrillation and Venous Thromboembolism (ex-US)Education Internal Medicine All Raising Awareness and Promoting Timely Diagnosis of TTR AmyloidosisRelease Date:Partner: Global Bridges at Mayo ClinicQuality Improvement Rare Disease All Accord for a Healthier World: Antimicrobial Resistance Testing & Stewardship to Improve Hospitalized Patients’ Health OutcomesRelease Date:Quality Improvement Hospital Malawi, Rwanda, Senegal Updates in Post-COVID Conditions: Potential Causes, Assessment, Testing, Management, and Ongoing ResearchRelease Date:Education Vaccines USA